Inventor profile of:

Mark D. Erion

City:

Del Mar, California

Country:

United States

Published Applications:

38

Last publication date:

2019-03-21

Top Assignees for applications by Mark D. Erion

The entities that hold a legal rights for patent applications filed by inventor Erion Mark D.:

Recent patent applications by Erion Mark D.

Mark D. Erion from Del Mar, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-03-21
US20190083515A1
Human necessities

Thyromimetics for the treatment of fatty liver diseases

#2 | 2018-10-25
US20180303856A1
Human necessities

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#3 | 2017-04-27
US20170112864A1
Human necessities

Thyromimetics for the treatment of fatty liver diseases

#4 | 2017-04-06
US20170096440A1
Chemistry; metallurgy

Activators of glucokinase

#5 | 2016-09-15
US20160263132A1
Human necessities

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#6 | 2015-06-18
US20150166590A1
Chemistry; metallurgy

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#7 | 2015-04-30
US20150119365A1
Chemistry; metallurgy

Activators of glucokinase

#8 | 2012-10-25
US20120270842A1
Human necessities

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#9 | 2012-04-19
US20120093729A1
Chemistry; metallurgy

Phosphorus-containing prodrugs

#10 | 2011-12-01
US20110294758A1
Chemistry; metallurgy

Activators of glucokinase

#11 | 2011-01-13
US20110009356A1
Chemistry; metallurgy

Phosphorus-containing prodrugs

#12 | 2010-04-01
US20100081634A1
Chemistry; metallurgy

Novel Phosphorus-Containing Thyromimetics

#13 | 2009-09-17
US20090232879A1
Human necessities

Thyromimetics for the Treatment of Fatty Liver Diseases

#14 | 2009-08-06
US20090197836A1
Human necessities

Combination of FBPase Inhibitors and Antidiabetic Agents Useful for the Treatment of Diabetes

#15 | 2009-07-21
US9900364
-

Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes

#16 | 2009-05-21
US20090131370A1
Chemistry; metallurgy

Novel Nucleoside Derivatives

#17 | 2009-05-07
US20090118236A1
Chemistry; metallurgy

Phosphorus-containing thyromimetics

#18 | 2009-05-07
US20090118223A1
Chemistry; metallurgy

Novel 2'-c-methyl and 4'c-methyl nucleoside derivatives

#19 | 2009-01-29
US20090028925A1
Chemistry; metallurgy

Novel Phosphinic Acid-Containing Thyromimetics

#20 | 2008-05-29
US20080125605A1
Chemistry; metallurgy

Phosphorus-containing prodrugs

#21 | 2008-01-17
US20080015195A1
Chemistry; metallurgy

Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase

#22 | 2008-01-03
US20080004226A1
Human necessities

Combination of FBPase Inhibitors and Insulin Sensitizers for the Treatment of Diabetes

#23 | 2007-12-25
US10636474
-

Heteroaromatic inhibitors of fructose 1,6-bisphosphatase

#24 | 2007-10-25
US20070249564A1
Chemistry; metallurgy

Novel phosphorus-containing prodrugs

#25 | 2007-10-04
US20070232571A1
Chemistry; metallurgy

Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase

#26 | 2007-08-02
US20070179114A1
Chemistry; metallurgy

Novel 2'-C methyl nucleoside derivatives

#27 | 2007-05-08
US10436922
-

Phosphonic acid based prodrugs of PMEA and its analogues

#28 | 2007-04-17
US9518501
-

Phosphorus-containing prodrugs

#29 | 2007-02-22
US20070042989A1
Chemistry; metallurgy

2′-C-methyl nucleoside derivatives

#30 | 2007-02-15
US20070037774A1
Chemistry; metallurgy

Cytarabine monophosphate prodrugs

#31 | 2006-12-19
US10698928
-

Cytarabine monophosphate prodrugs

#32 | 2006-03-02
US20060046980A1
Chemistry; metallurgy

Phosphorus-containing thyromimetics

#33 | 2005-12-29
US20050288240A1
Chemistry; metallurgy

Prodrugs for phosphorus-containing compounds

#34 | 2005-12-15
US20050277619A1
Chemistry; metallurgy

Purine inhibitors of fructose-1,6-bisphosphatase

#35 | 2005-11-22
US10615563
-

Purine inhibitors of fructose-1,6-bisphosphatase

#36 | 2005-09-20
US9978454
-

Prodrugs for phosphorus-containing compounds

#37 | 2005-08-18
US20050182252A1
Chemistry; metallurgy

Novel 2'-C-methyl nucleoside derivatives

#38 | 2005-05-12
US20050101775A1
Chemistry; metallurgy

Prodrugs for liver specific drug delivery

InventorID:

1145484 ⎘